ANSELMO PHARMA
Timeline
9 events since 2023Filings
Financial
Establishments
2023202420252026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 10 days late
2025
Highest result from 2023 to 2025 net €62,258 ▲3.6% The operating result of €110,285 and the net result of €62,258 are both a record.
Equity above €150,000 equity €183,073 ▲50.5% With a profit in every financial year since 2023, equity grows to €183,073.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0798184888
Annual accounts 2024 filed PDFabbreviated format · 3 days before the deadline
2024
Equity above €100,000 equity €121,647 ▲97.7% With a profit in every financial year since 2023, equity grows to €121,647.
Annual accounts 2023 filed PDFabbreviated format · 26 days late
2023
First establishment Draakplaats 4, Antwerp
IncorporationFounding capital of €25,000, 100 shares · Founded by · appointed as director · published on 09-02-20233 points ▸
- Founded by
- The founding capital is €25,000, divided into 100 shares
- appointed as director
- The deed holds 3 more points.
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank